What medications are recommended for symptomatic ventricular septal defect (VSD) in infants or children, including dosing and monitoring?

Medical Management of Symptomatic VSD in Infants and Children

For symptomatic infants with large VSDs and heart failure, initiate diuretics as first-line therapy, followed by ACE inhibitors (captopril 0.3-1.5 mg/kg/day divided every 8 hours or enalapril 0.1-0.5 mg/kg/day once or twice daily), with consideration of adding propranolol to reduce hospitalizations and prevent worsening heart failure symptoms.

First-Line Medical Therapy

Diuretics + ACE Inhibitors

• ACE inhibitors are essential medications for chronic heart failure in children with VSDs 1
• These agents lower left and right atrial pressures, decrease systemic vascular resistance, and reduce left-to-right shunting in infants with elevated systemic vascular resistance 1
• Captopril dosing: Start at 0.3 mg/kg/day, titrate gradually to target of 1.5 mg/kg/day, administered every 8 hours 1
• Enalapril dosing: 0.1-0.5 mg/kg/day, given once or twice daily 1
• Enalaprilat IV: 0.01-0.05 mg/kg/dose, one to three times daily for acute management 1

Critical monitoring: Watch for hypotension and renal failure within 5 days of starting or dose escalation. Start with smaller doses and increase gradually to prevent excessive hypotension 1. Recovery typically occurs after dose reduction or cessation 1.

Beta-Blocker Therapy: Propranolol

Propranolol should be considered as add-on therapy based on the most recent high-quality evidence from 2021 2:

• Significantly reduces hospitalization risk (12.5% vs 32.5%, P=0.03) with number needed to treat of 5 2
• Prevents worsening of Ross heart failure class (5.41% vs 28.21%, P=0.01) 2
• Well tolerated with minimal safety concerns except rare bronchospasm 2
• Does not reduce mortality or need for surgery, but improves quality of life by preventing clinical deterioration 2

The Canadian guidelines 3 support beta-blocker consideration in children with reduced left ventricular ejection fraction (<40%) on optimal ACE inhibitor therapy, though this applies more broadly to heart failure rather than specifically to VSD.

Digoxin: Limited Role

Digoxin is NOT recommended as routine therapy for symptomatic VSD 3:

• Traditionally used in infants with large VSDs and pulmonary congestion, but no evidence shows improved contractility or clinical symptoms in this setting 3
• One study showed digoxin increased contractility index when added to diuretics, but did not improve symptoms or signs of heart failure 4
• No pediatric data support its use in structurally normal hearts with systolic dysfunction 3

Aldosterone Antagonists

Spironolactone may be added for patients not responding to ACE inhibitors and beta-blockers 3:

• Starting dose: 1 mg/kg/day, target maximum 2 mg/kg/day 3
• Monitor potassium and renal function before starting, within 7-14 days after initiation, and periodically thereafter 3
• Risk of hyperkalemia when combined with ACE inhibitors, especially with compromised renal function 3
• Re-evaluate any potassium supplementation 3
• Monitor for irreversible male gynecomastia 3

Acute/Perioperative Management

For infants with elevated pulmonary vascular resistance undergoing surgery 5:

• Intravenous vasodilators: Glyceryl trinitrate + phentolamine
• Oral sildenafil: Up to 1 mg/kg every 6 hours
• Prostacyclin nebulization for acute pulmonary hypertensive crisis rescue

Common Pitfalls to Avoid

1. Do not use digoxin routinely - despite traditional practice, evidence shows no clinical benefit in VSD-related heart failure 3, 4
2. Start ACE inhibitors at low doses - hypotension and renal failure typically occur within 5 days of initiation or dose increase 1
3. Monitor electrolytes closely when combining ACE inhibitors with spironolactone - hyperkalemia risk is significant 3
4. Consider propranolol early - the 2021 trial shows clear benefit in preventing hospitalization and clinical deterioration 2
5. Screen for bronchospasm when using propranolol in infants 2

Treatment Algorithm

1. Start with diuretics for symptomatic relief
2. Add ACE inhibitor (captopril or enalapril) at low dose, titrate gradually
3. Consider adding propranolol to prevent hospitalizations and worsening symptoms
4. Reserve spironolactone for inadequate response to ACE inhibitor + beta-blocker
5. Avoid routine digoxin use - no proven benefit in this population
6. Refer for surgical closure if medical management fails or patient meets surgical criteria